Yo-Ting Tsai

Also affiliated with National Cancer Institute, Center for Cancer Research

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “First-in-human phase Ib trial of M9241 (NHS-IL12) plus avelumab in patients with advanced solid tumors, including dose expansion in patients with advanced urothelial carcinoma”.

First-in-human phase Ib trial of M9241 (NHS-IL12) plus avelumab in patients with advanced solid tumors, including dose expansion in patients with advanced urothelial carcinoma

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-005813

N/A

0.810DataRank · unranked

25 citations

Jean‐Laurent Deville, Mario Sznol, Alain Ravaud, Marco Maruzzo, Russell K. Pachynski +14 more

Efficacy, safety, and biomarker analyses of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with advanced non-small cell lung cancer

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008480

N/A

0.612DataRank · unranked

19 citations

Houssein Abdul Sater, Osama E. Rahma, Richy Agajanian, Wiem Lassoued, Jennifer L. Marté +13 more

6 Immune correlates of clinical benefit in patients with HPV-associated malignancies treated with bintrafusp alfa

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-sitc2021.006

N/A

0DataRank · unranked

0 citations

Renee N. Donahue, Nicole J. Toney, Julius Strauss, James L. Gulley, Jeffrey Schlom +1 more

A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer

The Oncologist(2022)10.1093/oncolo/oyab046

N/A

0DataRank · unranked

51 citations

Yo-Ting Tsai, Benjamin A. Weinberg, Renee N. Donahue, Shruti U. Gandhy, Margaret E. Gatti‐Mays +14 more

Joint-Predominant Rheumatic Complications of Immune Checkpoint Inhibitor Therapy in Patients with Thymic Epithelial Tumors

The Oncologist(2022)10.1093/oncolo/oyac026

N/A

0DataRank · unranked

4 citations

Madison Ballman, Haobin Chen, Shannon Swift, Meredith J. McAdams, Yo-Ting Tsai +8 more

Interrogation of the cellular immunome of cancer patients with regard to the COVID-19 pandemic

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-002087

N/A

0DataRank · unranked

10 citations

Jennifer L. Marté, Meghali Goswami, Nicole J. Toney, Yo-Ting Tsai, James L. Gulley +2 more

AB016. Phase 2 clinical trial of PT-112 in patients with thymic epithelial tumors

Mediastinum(2023)10.21037/med-23-ab016

N/A

0DataRank · unranked

3 citations

Shannon Swift, Renee N. Donahue, Carolina Celades, Yo-Ting Tsai, Molly A. Bingham +14 more

781 A phase II, open-label trial of bintrafusp alfa (M7824) in subjects with thymoma and thymic carcinoma (trial in progress)

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.0781

N/A

0DataRank · unranked

2 citations

Shannon Swift, Renee N. Donahue, Carolina Celades, Yo-Ting Tsai, Molly A. Bingham +11 more

Blood-based biomarkers in patients with non-small cell lung cancer treated with immune checkpoint blockade

Journal of Experimental & Clinical Cancer Research(2024)10.1186/s13046-024-02969-1

N/A

0DataRank · unranked

46 citations

Jeffrey Schlom, Renee N. Donahue, Yo-Ting Tsai

A T cell receptor β chain–directed antibody fusion molecule activates and expands subsets of T cells to promote antitumor activity

Science Translational Medicine(2023)10.1126/scitranslmed.adi0258

N/A

0DataRank · unranked

23 citations

Renee N. Donahue, Madan Katragadda, Jessica Lowry, Wei Huang, Karunya Srinivasan +15 more

582 Immune correlates from QuEST1 in men with castration-resistant prostate cancer

Regular and Young Investigator Award Abstracts(2021)10.1136/jitc-2021-sitc2021.582

N/A

0DataRank · unranked

2 citations

Yo-Ting Tsai, Jason M. Redman, James L. Gulley, Jeffrey Schlom, Renee N. Donahue +1 more